Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (151-160 of 721) with videos related to

Pageof 73
Sort By:
Journal of Nuclear Medicine Technology|March 4, 2010
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approachesAndreas K Buck, Ken Herrmann, Tom Stargardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2013
Evaluation of the Genisys4, a bench-top preclinical PET scannerKen Herrmann, Magnus Dahlbom, David Nathanson, et al.
Cancers|January 21, 2023
Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New ApproachesPhilip Posdzich, Christopher Darr, Thomas Hilser, et al.
Seminars in Nuclear Medicine|November 7, 2022
Molecular Imaging of Lymphoma: Future Directions and PerspectivesKelsey L Pomykala, Wolfgang P Fendler, Ophir Vermesh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2023
Risk and Incidence of Endocrine Immune-Related Adverse Effects Under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors: A Meta-Analysis of Randomized Controlled TrialsIrfan Vardarli, Susanne Tan, Tim Brandenburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
α-Therapy and Combination Strategies to Overcome Resistance and Enhance Clinical Outcomes in Prostate CancerAnna Karmann, Stephen Rose, Ken Herrmann, et al.
Medicine|September 22, 2020
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapyMiriam Sraieb, Nader Hirmas, Rupert Conrad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapyMark Konijnenberg, Ken Herrmann, Carsten Kobe, et al.
European Journal of Hybrid Imaging|December 20, 2021
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerDavid Kersting, Christoph Rischpler, Till Plönes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2020
Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisMaria Papathanasiou, Alexander Carpinteiro, Tim Hagenacker, et al.
Pageof 73

Showing results (151-160 of 721) with videos related to

Sort By:
Pageof 73
Journal of Nuclear Medicine Technology|March 4, 2010
Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approachesAndreas K Buck, Ken Herrmann, Tom Stargardt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 2013
Evaluation of the Genisys4, a bench-top preclinical PET scannerKen Herrmann, Magnus Dahlbom, David Nathanson, et al.
Cancers|January 21, 2023
Metastatic Prostate Cancer-A Review of Current Treatment Options and Promising New ApproachesPhilip Posdzich, Christopher Darr, Thomas Hilser, et al.
Seminars in Nuclear Medicine|November 7, 2022
Molecular Imaging of Lymphoma: Future Directions and PerspectivesKelsey L Pomykala, Wolfgang P Fendler, Ophir Vermesh, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2023
Risk and Incidence of Endocrine Immune-Related Adverse Effects Under Checkpoint Inhibitor Mono- or Combination Therapy in Solid Tumors: A Meta-Analysis of Randomized Controlled TrialsIrfan Vardarli, Susanne Tan, Tim Brandenburg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
α-Therapy and Combination Strategies to Overcome Resistance and Enhance Clinical Outcomes in Prostate CancerAnna Karmann, Stephen Rose, Ken Herrmann, et al.
Medicine|September 22, 2020
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapyMiriam Sraieb, Nader Hirmas, Rupert Conrad, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapyMark Konijnenberg, Ken Herrmann, Carsten Kobe, et al.
European Journal of Hybrid Imaging|December 20, 2021
Atypical bilateral ventilation/perfusion mismatches in an asymptomatic patient suffering from metastatic thyroid cancerDavid Kersting, Christoph Rischpler, Till Plönes, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 16, 2020
Publisher Correction to: 18F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosisMaria Papathanasiou, Alexander Carpinteiro, Tim Hagenacker, et al.
Pageof 73